Sign Out
Use in pregnant women and nursing mothers: Safety of SKYCellflu Quadrivalent has not been evaluated in pregnant women. Direct and/or indirect adverse effect related to reproduction and developmental toxicity was not observed in animal studies. SKYCellflu Quadrivalent should be administered to pregnant women or women of child-bearing potential only if clearly needed.
Safety of SKYCellflu Quadrivalent has not been evaluated in breastfeeding women. Since it is not known whether SKYCellflu Quadrivalent is excreted in breast milk, caution should be exercised when SKYCellflu Quadrivalent is administered to a nursing mother.
